ATE126237T1 - Lymphocyteninhibierung durch hla-peptide. - Google Patents

Lymphocyteninhibierung durch hla-peptide.

Info

Publication number
ATE126237T1
ATE126237T1 AT88901989T AT88901989T ATE126237T1 AT E126237 T1 ATE126237 T1 AT E126237T1 AT 88901989 T AT88901989 T AT 88901989T AT 88901989 T AT88901989 T AT 88901989T AT E126237 T1 ATE126237 T1 AT E126237T1
Authority
AT
Austria
Prior art keywords
ctl
peptides
hla peptides
alpha
lymphocyte inhibition
Prior art date
Application number
AT88901989T
Other languages
English (en)
Inventor
Alan M Krensky
Peter Parham
Carol Clayberger
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of ATE126237T1 publication Critical patent/ATE126237T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88901989T 1987-01-30 1988-01-27 Lymphocyteninhibierung durch hla-peptide. ATE126237T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US884687A 1987-01-30 1987-01-30
US13854787A 1987-12-24 1987-12-24

Publications (1)

Publication Number Publication Date
ATE126237T1 true ATE126237T1 (de) 1995-08-15

Family

ID=26678694

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88901989T ATE126237T1 (de) 1987-01-30 1988-01-27 Lymphocyteninhibierung durch hla-peptide.

Country Status (7)

Country Link
EP (1) EP0365525B1 (de)
AT (1) ATE126237T1 (de)
AU (1) AU619458B2 (de)
CA (1) CA1339185C (de)
DE (1) DE3854300T2 (de)
DK (1) DK549188A (de)
WO (1) WO1988005784A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011834B1 (en) 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
US5723128A (en) * 1987-01-30 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
JP3015058B2 (ja) * 1989-03-03 2000-02-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 表面レセプター活性のクラスｉｍｈｃ調節
DE4143467C2 (de) * 1991-05-17 1995-02-09 Max Planck Gesellschaft Peptidmotiv und dessen Verwendung
EP0661985B1 (de) * 1991-11-08 1999-07-07 The Board Of Trustees Of The Leland Stanford Junior University Peptide, die cd8 moleküle auf ctl-vorläufern binden
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin
CA2142007C (en) * 1992-08-11 2007-10-30 Robert Glen Urban Immunomodulatory peptides
DE4238416A1 (de) * 1992-11-13 1994-05-19 Max Planck Gesellschaft Bestimmung von Peptidmotiven auf MHC-Molekülen
WO1994019009A1 (en) * 1993-02-17 1994-09-01 Immune Network Research Ltd. Methods for modifying the t cell repertoire of the immune system
US6162434A (en) * 1995-05-03 2000-12-19 Sangstat Medical Corporation Cytomodulating peptide for inhibiting lymphocyte activity
US5753625A (en) * 1995-05-12 1998-05-19 Sangstat Medical Corporation Treatment for inhibiting the progression of autoimmune disease
WO1997008328A1 (en) * 1995-08-30 1997-03-06 The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services Selective elimination of t cells that recognize specific preselected targets
US6436903B1 (en) 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
WO1997044351A1 (en) * 1996-05-24 1997-11-27 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
WO1998046633A1 (en) 1997-04-11 1998-10-22 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
US6696545B1 (en) 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
AU2003210659A1 (en) 2002-01-24 2003-09-02 Sangstat Medical Corporation Combination therapy for treatment of hiv infection
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis

Also Published As

Publication number Publication date
EP0365525A4 (en) 1990-12-12
WO1988005784A1 (en) 1988-08-11
DK549188D0 (da) 1988-09-30
AU619458B2 (en) 1992-01-30
DK549188A (da) 1988-11-30
EP0365525A1 (de) 1990-05-02
CA1339185C (en) 1997-07-29
DE3854300T2 (de) 1996-01-11
AU1342388A (en) 1988-08-24
EP0365525B1 (de) 1995-08-09
DE3854300D1 (de) 1995-09-14

Similar Documents

Publication Publication Date Title
DE3854300D1 (de) Lymphocyteninhibierung durch hla-peptide.
ES2128362T3 (es) Fragmentos de proteinas de prion.
DK0631502T3 (da) Lymfocytaktivitetsregulering ved hjælp af HLA-peptider
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
ES2056817T3 (es) Transformacion de trichoderma.
IL94039A0 (en) Antibodies to anti-cytotoxic proteins
DK0503648T3 (da) CD2-bindingsdomæne af lymfocytfunktion-associeret antigen 3
ES2181674T3 (es) Dominios de union en las proteinas notch y delta.
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
DE68926675D1 (de) Von mhc gestützte konjugate zur verwendung bei der steigerung der autoimmunität
ES2120964T3 (es) Peptidos osteogenicos.
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
IL134982A0 (en) Antibodies which react with polypeptides of cd-44 surface proteins and diagnostic and pharmaceutical compositions prepared therewith
AU5214893A (en) Antibodies specific to extracellular segments of human and immunoglobulin anchoring peptides
JPS6456697A (en) Viii factor bonded domain of von willebrand's factor
ES2186717T3 (es) Regulacion de la actividad de los linfocitos t citotoxicos ("ctl") mediante peptidos de la clase i del mhc.
ATE63126T1 (de) Tetra- und penta-peptide mit der sequenz lysylarginyl-aspartyl, und ihre verwendung als antithrombotika.
ATE201994T1 (de) Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut
ATE225806T1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
DK0625157T3 (da) Blodplade-GPIIIaP1A1- og -P1A2-epitoper og fremstilling og anvendelse deraf
DE3751834D1 (de) Selbstantigen der primären lebercirrhose
ATE196767T1 (de) Neue cocain-derivate und protein- und polypeptid- cocain-derivate, konjugate und markierte verbindungen
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
ES2145061T3 (es) Diagnostico y terapia a base de peptidos para el tratamiento de las espondiloartropatias.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee